- Trials with a EudraCT protocol (44,393)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44,393 result(s) found.
Displaying page 328 of 2,220.
| EudraCT Number: 2007-001114-17 | Sponsor Protocol Number: WA19923 | Start Date*: 2007-12-12 |
| Sponsor Name:F. Hoffmann-La Roche Limited | ||
| Full Title: A Mechanism of Action study to evaluate the effects of IL-6 receptor blockade with tocilizumab (TCZ) on lipids, arterial stiffness, and markers of atherogenic risk in patients with moderate to seve... | ||
| Medical condition: Rheumatoid Arthritis (RA) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: Removed from public view | ||
| EudraCT Number: 2007-001096-10 | Sponsor Protocol Number: S308.3.009 | Start Date*: 2008-03-27 | |||||||||||
| Sponsor Name:Solvay Pharmaceuticals | |||||||||||||
| Full Title: An Extension of the Van Gogh Study: An Open Label SLV308 Safety Extension to Study S308.3.004 in Patients with Parkinson’s Disease Experiencing Motor Fluctuations | |||||||||||||
| Medical condition: advanced stage of idiopathic PD with dose-dependent motor fluctuations. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Prematurely Ended) SK (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-001009-41 | Sponsor Protocol Number: grim1001 | Start Date*: 2008-10-08 | |||||||||||
| Sponsor Name:Imperial College Healthcare NHS trust | |||||||||||||
| Full Title: mycophenylate mofetil and tacrolimus vs tacrolimus alone for the treatment of nephrotic syndrome secondary to idiopathic membranous glomerulonephritis | |||||||||||||
| Medical condition: Idiopathic Membranous Glomerulonephritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-001865-28 | Sponsor Protocol Number: 08/H0802/9 | Start Date*: 2008-05-30 | ||||||||||||||||
| Sponsor Name:King's College London [...] | ||||||||||||||||||
| Full Title: The Relationship between Osteoporosis and Aortic Calcification in Postmenopausal Women | ||||||||||||||||||
| Medical condition: Osteoporosis; Aortic Calcification | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2007-001743-21 | Sponsor Protocol Number: BS 594 | Start Date*: 2007-06-19 | |||||||||||
| Sponsor Name:Generics (UK) Ltd. | |||||||||||||
| Full Title: A PHASE II DOUBLE BLIND MODIFIED CROSS OVER DESIGN STUDY EVALUATING THE EFFICACY AND SAFETY OF TRIMETAZIDINE (GENERICS UK LIMITED) AND PLACEBO IN THE TREATMENT OF FIBROMYALGIA | |||||||||||||
| Medical condition: Fibromyalgia | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-001744-53 | Sponsor Protocol Number: PAI study | Start Date*: 2008-04-02 | ||||||||||||||||
| Sponsor Name:University of Leipzig | ||||||||||||||||||
| Full Title: Open, randomized study for evaluation of an active Hepatitis B vaccination(HBVAXPRO) in combination with a passive immunisation with Hepatitis B immunoglobulins (Hepatect) for subjects, who did not... | ||||||||||||||||||
| Medical condition: Hepatitis B immunization | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2007-001782-15 | Sponsor Protocol Number: IGG-FC-GR/DEX21P | Start Date*: 2008-04-09 | |||||||||||
| Sponsor Name:ISTITUTO GIANNINA GASLINI | |||||||||||||
| Full Title: Efficacy and safety of Intra-erythrocytes dexamethasone in cystic fibrosis | |||||||||||||
| Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-005194-30 | Sponsor Protocol Number: P-AD337-021 | Start Date*: 2006-06-12 |
| Sponsor Name:Arakis Ltd. | ||
| Full Title: A multi-centre, randomised, double-blind, placebo controlled, parallel group exploratory study to investigate the efficacy, safety and tolerability of AD 337 in the treatment of fibromyalgia in fem... | ||
| Medical condition: Fibromyalgia | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-005217-38 | Sponsor Protocol Number: DSHNHL2004-2 | Start Date*: 2008-07-25 | |||||||||||
| Sponsor Name:German High Grade Non-Hodgkins Lymphoma group | |||||||||||||
| Full Title: Randomiseret forsøg der sammenligner 4 og 6 kemoterapicykler med CHOP (Cyklofosfamid, Doxorubicin, Vincristin og Prednison) i 21-dages intervaller, begge med 6 cykler immunterapi med monoklonalt an... | |||||||||||||
| Medical condition: Patients with untreated aggressive CD20+ Non-Hodgkins Lymphoma aged 18 to 60 years without major accompanying disorders with no risk factor according to IPI and no bulky disease (<7,5cm) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-003913-28 | Sponsor Protocol Number: CB-01-02/04 | Start Date*: 2009-05-25 | |||||||||||
| Sponsor Name:COSMO TECHNOLOGIES LTD | |||||||||||||
| Full Title: Randomised, double-blind,multicentre,12 months extension study to evaluate the safety and the efficacy of daily Budesonide MMX 6mg vs placebo in the maintenance of remission in subjects with ulcera... | |||||||||||||
| Medical condition: Mild to moderate ulcerative colitis. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-005530-21 | Sponsor Protocol Number: AGO/2006/010 | Start Date*: 2007-01-12 | |||||||||||
| Sponsor Name:University Hospital Gent | |||||||||||||
| Full Title: Comparison of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with gadofosveset trisodium (Vasovist, Schering, Berlin, Germany) to gadopentetate dimeglumine (GD-DTPA, Magnevist, Sche... | |||||||||||||
| Medical condition: Metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-005549-12 | Sponsor Protocol Number: P060102 | Start Date*: 2007-05-04 | |||||||||||
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
| Full Title: Chimiothérapie par Témozolomide dans le traitement des glioblastomes supratentoriels des sujets de 70 ans et plus présentant un état fonctionnel altéré (IK<70). | |||||||||||||
| Medical condition: Patients de 70 ans et plus atteints de glioblastomes supratentoriels et présentant un état fonctionnel altéré. | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-005557-30 | Sponsor Protocol Number: FB/PS/14/165/06 | Start Date*: 2007-03-16 | |||||||||||
| Sponsor Name:Chiesi Farmaceutici S.p.A. | |||||||||||||
| Full Title: In-vivo deposition measurement of formoterol and beclomethasone after inhalation of a single dose of the combination Formoterol plus BDP HFA pMDI (Foster®, Chiesi) in healthy volunteers, asthmatic... | |||||||||||||
| Medical condition: The study is focused on asthma bronchiale and chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-005564-12 | Sponsor Protocol Number: IASON | Start Date*: 2007-05-25 |
| Sponsor Name:Laboratoire IASON | ||
| Full Title: Imagerie fonctionnelle de l'hypoxie du cancer du col utérin par 18F-FETNIM TEP/TDM | ||
| Medical condition: Quantification du degré d'hypoxie par mesure de la fixation du 18F-FETNIM par TEP/TDM avant traitement radio-chimiothérapeutique et après le prélèvement histologique. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-005578-39 | Sponsor Protocol Number: PKI108574 | Start Date*: 2007-01-18 | |||||||||||
| Sponsor Name:GlaxoSmithKline | |||||||||||||
| Full Title: A randomised, double-blind, placebo-controlled study to explore the antidepressant properties of the P38a kinase inhibitor GW856553X 15mg compared to placebo in subjects with Major Depressive Disor... | |||||||||||||
| Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: EE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-000506-36 | Sponsor Protocol Number: 12213A | Start Date*: 2009-03-13 | |||||||||||
| Sponsor Name:H. Lundbeck A/S | |||||||||||||
| Full Title: Randomised, double-blind, parallel-group, placebo-controlled, fixed-dose comparison study of escitalopram in combination with two fixed doses of gaboxadol to escitalopram in Major Depressive Disorder | |||||||||||||
| Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-003171-39 | Sponsor Protocol Number: PSD502-PE-004 | Start Date*: 2007-12-07 | |||||||||||
| Sponsor Name:Plethora Solutions Ltd | |||||||||||||
| Full Title: A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PDS502 in subjects with Premature Ejac... | |||||||||||||
| Medical condition: Premature Ejaculation | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: GB (Completed) HU (Completed) CZ (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-007394-22 | Sponsor Protocol Number: PK11195 | Start Date*: 2008-05-22 | |||||||||||
| Sponsor Name:Imperial College London | |||||||||||||
| Full Title: The role of white and grey matter and meningeal inflammation in multiple sclerosis (MS) and clinically isolated syndromes (CIS) as quantified using [(11)C](R)-PK11195 positron emission tomography (... | |||||||||||||
| Medical condition: Multiple Sclerosis | |||||||||||||
|
|||||||||||||
| Population Age: | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-003677-10 | Sponsor Protocol Number: CSPP100AGB01 | Start Date*: 2007-10-02 |
| Sponsor Name:Novartis Pharmaceuticals UK Ltd | ||
| Full Title: A twelve week, randomized, double-blind, parallel-group multicentre study to evaluate the efficacy and safety of the combination of aliskiren/ramipril/amlodipine (300/10/10mg), compared to the com... | ||
| Medical condition: patients with essential hypertension and metabolic syndrome. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-003277-19 | Sponsor Protocol Number: nd | Start Date*: 2007-09-03 | |||||||||||
| Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
| Full Title: modifications on the pain-threshold in labour and the effects of the epidural analgesia and S-Ketamina on the pai-threshold | |||||||||||||
| Medical condition: pain-threshold | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.